Having shown that TOPK knock-down resulted in enhancement of apoptosis and decrease in cell viability, we then examined whether targeting TOPK kinase activity with a recently developed TOPK inhibitor OTS514 [41] would result in a cytotoxic effect in AML cells. The gene discussed is PBK; the disease is acute myeloid leukemia.